MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children

A Cohort of Pre-pubertal Children for the Study of Optimization of Methods of Administration of the Biosynthetic Growth Hormone MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation

1. To test for equivalence in terms of catch-up growth between the 2 therapeutic regimens
2. To specify the best period of treatment
3. To assess the efficacy of treatment based on final adult height of these children

Inclusion Criteria:

• Pre-pubertal children of either sex presenting with severe early onset intrauterine growth retardation (I.U.G.R.)
• Height Less Than or Equal to -3 SD

Exclusion Criteria:

• Age less than 3 years

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.